Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

C19 Economics site

Three Key Gaps in the Health Economics Research on COVID-19, and Why It Matters

The online platform C19economics was created to support researchers and decision makers by collating the health economic literature published on the COVID-19 pandemic into an easily searchable repository. After reviewing the literature, we found three notable gaps in coverage in terms of geographical focus and topic areas. 

An image of an African doctor wearing protective mask and gloves using tablet working in clinic.

The New C19economics.org: A Platform to Support the Generation and Use of Health Economics Research to Tackle COVID-19

Since the beginning of the COVID-19 outbreak, the scientific community has worked around the clock to produce evidence to support decision-makers in all aspects of pandemic management. As of April 2021, there are more than 78,000 articles published in peer reviewed journals and pre-prints (as indexed by collabovid.org). Those unprecedented collective research efforts have supported decisionmakers across the world on some of the toughest choices in decades, from closing economies, to procuring vaccines and medical supplies and equipment, and preparing for the uncertain year ahead.

A table of next steps for the COVID multi-model comparison collaboration

The COVID-19 Multi-model Comparison Collaboration Releases Its First Two Outputs

Since April 2020, a group of national governments, funders, and development partners supporting COVID-19 responses in low- and middle-income countries have been working together as the COVID-19 Multi-model Comparison Collaboration (CMCC) to support the use of epidemiological models during the COVID-19 pandemic. Today, the CMCC releases its first two outputs—an important step towards enhancing the informed use of models in COVID-related policymaking.

A close-up of some pills

Healthcare Technologies and COVID-19: Speed is Not Always a Good Thing

With a focus on tests, treatments, and a vaccine, we take a look at the emerging global clinical and economic evidence-base underpinning some of these technologies, the mechanisms (mostly global) for financing these commodities, and, finally, the decision-making processes for selecting technologies. This includes identifying the right subpopulations and negotiating a cost-effective tiered price across countries and regions.

Pages